- ►diabetesjournals.org L Davies, EG Wilmshurst, A McElduff, J Gunton, P … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—A total of 198 subjects (76%) had normoalbuminuria (<20 μg/min), 50 subjects
(19%) had microalbuminuria (20–200 μg/min), and 12 subjects (5%) had macroalbuminuria
(≥200 μg/min). Those with microalbuminuria had higher levels of tHcy than those with ... Cited by 52 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org A Jager, PJ Kostense, G Nijpels, JM Dekker, … - … , and vascular biology, 2001 - Am Heart Assoc Abstract—Microalbuminuria is a strong indicator of the risk of future cardiovascular disease and
renal dysfunction. Slightly increased levels of homocysteine, an independent risk factor for atherothrombotic
disease, have recently been found to be associated with the presence of ... Cited by 63 - Related articles - BL Direct - All 7 versions
M Lanfredini, P Fiorina, MG Peca, A Veronelli, A Mello, … - Metabolism, 1998 - Elsevier The study aim was to assess the relationship between homocyst(e)inemia and microalbuminuria
in non—insulin-dependent diabetes mellitus (NIDDM) patients. The study was performed on
33 NIDDM patients (16 males and 17 females), and 16 healthy control subjects (seven ... Cited by 61 - Related articles - BL Direct - All 6 versions
SP Stabler, R Estacio, BW Jeffers, JA Cohen, RH Allen, … - Metabolism, 1999 - Elsevier Non—insulin-dependent diabetes mellitus (NIDDM) and hyperhomocysteinemia are both associated
with premature vascular disease. We tested the hypothesis that homocysteine is associated with
vascular disease and other diabetic complications in patients with NIDDM. The current ... Cited by 72 - Related articles - BL Direct - All 5 versions
JA Cohen, BW Jeffers, S Stabler, RW Schrier, R … - Autonomic Neuroscience, 2001 - Elsevier Objective: To determine if hyperhomocysteinemia is a risk factor for the development of diabetic
sensorimotor peripheral neuropathy (DSPN) and diabetic autonomic neuropathy (DAN).
Background: Hyperhomocysteinemia and non-insulin-dependent diabetes mellitus ... Cited by 18 - Related articles - All 7 versions
- ►diabetesjournals.org [PDF] YM Smulders, M Rakic, EH Slaats, M Treskes, EJ … - Diabetes Care, 1999 - Am Diabetes Assoc NIDDM is associated with a sharply inc reased risk of cardiovascular dis- ease and mort alit
y. It is estimated that 65% of all patients die from card iovasc u- lar complications (1,2). Part of
this inc reased risk is explained by clustering of NIDDM with established risk factors for ... Cited by 111 - Related articles - BL Direct - All 9 versions
B Ozmen, D Ozmen, N Turgan, S Habif, I … - Annals of Clinical & …, 2002 - Assoc Clin Scientists Abstract. Homocysteinemia is an independent risk factor for cardiovascular disease, but information
on its association with type 2 diabetes and mild renal dysfunction is limited. Plasma total homocysteine
(tHcy) concentration is partly determined by renal plasma clearance. Serum cystatin C ... Cited by 43 - Related articles - BL Direct - All 4 versions
J Drzewoski, L Czupryniak, G Chwatko, E Bald - Diabetes, nutrition & …, 2000 - cat.inist.fr Elevated blood level of homocysteine is strongly related to an increased risk for atherosclerosis
and cardiovascular disease. The role of homocysteine in Type 2 diabetes vascular complications
remains unclear. Our objective was to investigate homocysteine levels in poorly ... Cited by 31 - Related articles - BL Direct - All 3 versions
EK Hoogeveen, PJ Kostense, C Jakobs, LM … - Journal of internal …, 1997 - dare.ubvu.vu.nl EK HOOGEVEENa , PJ KOSTENSEa c , C. JAKOBSd , LM BOUTERa c , RJ HEINEa b & CDA
STEHOUWERa b * From the aInstitute for Research in Extramural Medicine, bDepartment of
Internal Medicine, University Hospital, cDepartment of Epidemiology and Biostatistics, ... Cited by 38 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org M Emoto, H Kanda, T Shoji, T Kawagishi, M … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—Plasma tHcy levels and their log-transformed values (log tHcy) were significantly
higher in all patients with diabetes than in control subjects (tHcy, 12.0 ± 0.7 [SE] vs. 8.7 ± 0.3
μmol/l, P < 0.0001; log tHcy, 1.040 ± 0.021 vs. 0.920 ± 0.016 μmol/l, P < 0.0001). Plasma ... Cited by 80 - Related articles - BL Direct - All 6 versions
